Related Experiment Video
Updated: May 2, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
11.3K
Methylphenidate and suicidal ideation: Report of two cases
1Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India.
Indian Journal of Psychiatry
|February 28, 2014
Summary
Methylphenidate, prescribed for Attention Deficit Hyperactivity Disorder (ADHD), may trigger suicidal ideation in children. Symptoms resolved after discontinuing the medication, suggesting a potential link unrelated to depression or impulsivity.
Area of Science:
- Child and Adolescent Psychiatry
- Neuroscience
- Pharmacology
Background:
- Stimulant medications, including methylphenidate, are standard treatments for Attention Deficit Hyperactivity Disorder (ADHD).
- While generally effective, psychiatric side effects have been reported, such as psychosis and hallucinations.
- The potential for mood-related adverse events requires ongoing investigation.
Purpose of the Study:
- To report two cases of children with ADHD who developed suicidal ideation while treated with methylphenidate.
- To examine the relationship between methylphenidate treatment and the emergence of suicidal ideation.
- To differentiate this adverse event from typical depressive symptoms or impulsivity associated with ADHD.
Main Methods:
- Case report methodology.
- Clinical observation and documentation of psychiatric symptoms in pediatric patients.
- Assessment of symptom changes following medication discontinuation.
Main Results:
- Two children diagnosed with ADHD experienced new-onset suicidal ideation after initiating methylphenidate therapy.
- Suicidal ideation ceased in both cases upon withdrawal of methylphenidate.
- The reported suicidal ideation was not accompanied by depressive symptoms and could not be attributed to impulsivity.
Conclusions:
- Methylphenidate treatment in children with ADHD may be associated with the development of suicidal ideation.
- Discontinuation of methylphenidate can lead to the resolution of these ideation symptoms.
- Further research is warranted to understand the mechanism and prevalence of this specific adverse effect.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
01:24Mania and Antimanic Drugs: Overview
800
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
800
01:30Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
01:17Phase II Reactions: Methylation Reactions
915
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
915
01:28Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449